Nestle(US:NSRGY) Mei Ri Jing Ji Xin Wen·2026-01-08 11:41Core Viewpoint - Nestlé has initiated a voluntary recall of several batches of infant formula across more than 30 countries due to potential contamination with Bacillus cereus, a bacterium that can cause gastrointestinal issues in infants [1][3][12]. Group 1: Recall Details - The recall affects various products, including Nestlé BEBA Supreme, with specific batches identified as potentially contaminated [1][6]. - In Hong Kong, the Food and Environmental Hygiene Department confirmed the recall, citing concerns over Bacillus cereus contamination [3]. - A total of 41 batches of infant formula sold through cross-border e-commerce in mainland China are included in the recall, with brands such as Nan and Wyeth being affected [6][12]. Group 2: Consumer Reactions - Parents are expressing significant concern and anxiety over the recall, with many checking their products against the recall list and considering switching formulas [7][8]. - Some parents have reported adverse reactions in their children, such as vomiting and diarrhea, which they suspect may be linked to the affected formula [8][9]. - Despite the lack of reported adverse health effects related to the recalled products, parents remain apprehensive about potential long-term health impacts [7][9]. Group 3: Company Response and Market Impact - Nestlé has stated that the recall is a precautionary measure and has not received any reports of adverse effects related to the affected products [7][14]. - The company indicated that the affected batches represent less than 0.5% of its annual sales, suggesting minimal financial impact from the recall [12]. - The recall comes at a challenging time for Nestlé's Greater China region, which has recently merged its infant nutrition and Wyeth nutrition businesses, aiming for improved operational efficiency [14][15].